Colon cancer survival could be improved by exercising, finds a major study

A study involving 889 people with colon cancer has surprised many with their findings. 

Researchers conducted a structured exercise programme over a period of 3 years with patients soon after their chemotherapy. The trial monitored the impact of the physical activity programme in comparison to those who were offered just health education materials. As per the study, the exercises were tailored to each individual and varied from person to person. 

What is colon cancer?

Colon cancer, also known as colorectal cancer or bowel cancer, is a type of cancer that forms in the large intestine (colon). Globally, new colorectal cancer cases are predicted to reach 3.2 million in 2040, according to a study in Science Direct. 

Findings of the study:

It was observed that after five years, 80 per cent of the people in the group remained cancer free compared with the 74  per cent in the group where health education materials were provided. After a period of eight years, overall survival rate of 90 per  cent was noticed in the exercise group. 

“During the trial, we supported people to reach their weekly exercise target in a way that worked for them. This could be a brisk walk for around 40 minutes every day, but some patients were also doing circuit classes, cycling, swimming, and many other activities. Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer. We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate," said Professor Vicky Coyle, UK lead researcher for the trial. 

"It’s been almost five years since my cancer diagnosis and if I meet anyone, I tell them I am doing great. Taking part in the trial helped me so much – I am stronger, fitter, and my anxiety is better. I never thought at 69 years of age I would be able to do all of this – I am chuffed to bits," said 69-year-old Margaret Tubridy, from North Belfast, who took part in the clinical trial.

Health